{
    "model_info": {
        "version": "4.0",
        "description": "HIVEC-CM: HIV Epidemic Cameroon Model - Calibrated Parameters",
        "created": "2025-10-09T00:00:00Z",
        "notes": "Unified parameter system with historical calibration and scenario modifications"
    },
    "calibration_targets": {
        "source": "UNAIDS Cameroon estimates 2023",
        "hiv_prevalence": {
            "1990": 0.013,
            "2000": 0.045,
            "2010": 0.037,
            "2022": 0.028
        },
        "confidence_intervals": {
            "1990": [0.010, 0.016],
            "2000": [0.040, 0.051],
            "2010": [0.032, 0.043],
            "2022": [0.024, 0.032]
        }
    },
    "camphia_2017": {
        "source": "Cameroon Population-based HIV Impact Assessment 2017",
        "prevalence_by_age_sex": {
            "male_15_24": 0.018,
            "male_25_34": 0.025,
            "male_35_49": 0.032,
            "female_15_24": 0.029,
            "female_25_34": 0.042,
            "female_35_49": 0.048
        },
        "cascade_95_95_95": {
            "aware_of_status": 0.68,
            "on_art": 0.58,
            "virally_suppressed": 0.49
        },
        "viral_load_suppression": {
            "suppressed_below_1000": 0.75,
            "suppressed_below_400": 0.68
        }
    },
    "demographics": {
        "birth_rate": {
            "source": "World Bank World Development Indicators, Cameroon 1960-2023",
            "unit": "per_person_per_year",
            "historical_series": {
                "1985": 0.044648,
                "1990": 0.043643,
                "2000": 0.044,
                "2010": 0.038,
                "2020": 0.0353,
                "2022": 0.034
            },
            "projection": {
                "2030": 0.032,
                "2040": 0.028,
                "2050": 0.025
            }
        },
        "death_rate": {
            "source": "World Bank World Development Indicators",
            "unit": "per_person_per_year",
            "historical_series": {
                "1985": 0.0137,
                "1990": 0.0124,
                "2000": 0.0135,
                "2010": 0.0113,
                "2020": 0.0089,
                "2022": 0.0085
            }
        }
    },
    "prevention": {
        "condom_distribution": {
            "description": "Condom distribution and use rates over time",
            "source": "Cameroon national HIV prevention programs",
            "historical_coverage": {
                "1985_1999": {
                    "value": 0.12,
                    "note": "Pre-2000 baseline"
                },
                "2000_2009": {
                    "start": 0.12,
                    "end": 0.35,
                    "interpolation": "linear",
                    "note": "Early prevention scale-up"
                },
                "2010_2017": {
                    "start": 0.35,
                    "end": 0.65,
                    "interpolation": "linear",
                    "note": "Accelerated distribution"
                },
                "2018_2023": {
                    "value": 0.65,
                    "note": "Sustained high coverage"
                }
            },
            "transition_year": 2024,
            "scenario_targets": {
                "baseline": 0.65,
                "optimistic": 0.75,
                "pessimistic": 0.50
            }
        },
        "prep_coverage": {
            "description": "PrEP coverage for key populations",
            "historical_coverage": {
                "2010_2019": 0.0,
                "2020_2023": 0.10
            },
            "scenario_targets": {
                "baseline": 0.10,
                "optimistic": 0.30,
                "pessimistic": 0.05
            }
        }
    },
    "testing": {
        "general_population": {
            "description": "HIV testing rates in general population",
            "source": "Cameroon DHS and CAMPHIA surveys",
            "historical_coverage": {
                "1985_1999": {
                    "value": 0.02,
                    "note": "Minimal testing availability"
                },
                "2000_2009": {
                    "start": 0.02,
                    "end": 0.12,
                    "interpolation": "exponential",
                    "note": "Testing scale-up begins"
                },
                "2010_2019": {
                    "start": 0.12,
                    "end": 0.29,
                    "interpolation": "linear",
                    "note": "Rapid expansion"
                },
                "2020_2023": {
                    "value": 0.29,
                    "note": "Current level (CAMPHIA 2017 baseline)"
                }
            },
            "transition_year": 2024,
            "scenario_targets": {
                "baseline": 0.29,
                "optimistic": 0.38,
                "pessimistic": 0.22
            }
        },
        "key_populations": {
            "description": "Targeted testing for FSW, MSM, PWID",
            "historical_coverage": {
                "2010_2023": 0.45
            },
            "scenario_targets": {
                "baseline": 0.45,
                "optimistic": 0.60,
                "pessimistic": 0.35
            }
        }
    },
    "art_program": {
        "availability": {
            "start_year": 2004,
            "note": "ART became available in Cameroon in 2004"
        },
        "initiation": {
            "description": "Rate at which diagnosed individuals initiate ART",
            "source": "Cameroon national ART program data",
            "historical_rates": {
                "2004_2009": 0.30,
                "2010_2015": {
                    "start": 0.30,
                    "end": 0.65,
                    "interpolation": "linear"
                },
                "2016_2022": {
                    "start": 0.65,
                    "end": 0.85,
                    "interpolation": "linear"
                },
                "2023": 0.85
            },
            "transition_year": 2024,
            "scenario_targets": {
                "baseline": 0.85,
                "optimistic": 0.92,
                "pessimistic": 0.75
            }
        },
        "retention_12_months": {
            "description": "Proportion retained on ART at 12 months",
            "historical_rates": {
                "2004_2010": 0.70,
                "2011_2020": {
                    "start": 0.70,
                    "end": 0.90,
                    "interpolation": "linear"
                },
                "2021_2023": 0.90
            },
            "scenario_targets": {
                "baseline": 0.90,
                "optimistic": 0.95,
                "pessimistic": 0.83
            }
        },
        "retention_24_months": {
            "description": "Proportion retained on ART at 24 months",
            "historical_rates": {
                "2004_2010": 0.60,
                "2011_2020": {
                    "start": 0.60,
                    "end": 0.85,
                    "interpolation": "linear"
                },
                "2021_2023": 0.85
            },
            "scenario_targets": {
                "baseline": 0.85,
                "optimistic": 0.92,
                "pessimistic": 0.78
            }
        },
        "viral_suppression": {
            "description": "Viral suppression rate among those on ART",
            "source": "CAMPHIA 2017",
            "historical_rates": {
                "2004_2010": 0.55,
                "2011_2020": {
                    "start": 0.55,
                    "end": 0.75,
                    "interpolation": "linear"
                },
                "2021_2023": 0.75
            },
            "scenario_targets": {
                "baseline": 0.75,
                "optimistic": 0.85,
                "pessimistic": 0.68
            }
        },
        "treatment_interruption": {
            "description": "Rate of treatment interruptions due to stockouts",
            "historical_rates": {
                "2004_2015": 0.15,
                "2016_2023": 0.05
            },
            "scenario_targets": {
                "baseline": 0.05,
                "optimistic": 0.02,
                "pessimistic": 0.08
            }
        }
    },
    "pmtct": {
        "anc_coverage": {
            "description": "Antenatal care attendance rate",
            "source": "Cameroon DHS",
            "historical_coverage": {
                "1985_2002": 0.40,
                "2003_2010": {
                    "start": 0.40,
                    "end": 0.70,
                    "interpolation": "linear"
                },
                "2011_2019": {
                    "start": 0.70,
                    "end": 0.85,
                    "interpolation": "linear"
                },
                "2020_2023": 0.85
            },
            "scenario_targets": {
                "baseline": 0.85,
                "optimistic": 0.92,
                "pessimistic": 0.78
            }
        },
        "testing_at_anc": {
            "description": "HIV testing rate at ANC visits",
            "historical_coverage": {
                "1985_2002": 0.20,
                "2003_2010": {
                    "start": 0.20,
                    "end": 0.70,
                    "interpolation": "linear"
                },
                "2011_2023": 0.80
            },
            "scenario_targets": {
                "baseline": 0.80,
                "optimistic": 0.90,
                "pessimistic": 0.72
            }
        },
        "art_coverage_pregnant": {
            "description": "ART coverage for HIV+ pregnant women",
            "historical_coverage": {
                "1985_2002": 0.0,
                "2003_2010": {
                    "start": 0.0,
                    "end": 0.40,
                    "interpolation": "linear"
                },
                "2011_2019": {
                    "start": 0.40,
                    "end": 0.75,
                    "interpolation": "linear"
                },
                "2020_2023": 0.75
            },
            "scenario_targets": {
                "baseline": 0.75,
                "optimistic": 0.88,
                "pessimistic": 0.65
            }
        }
    },
    "funding_scenarios": {
        "description": "Funding multipliers and their effects",
        "baseline": {
            "multiplier": 1.0,
            "description": "Status quo funding"
        },
        "optimistic": {
            "multiplier": 1.2,
            "description": "20% increase in funding",
            "sensitivity_by_category": {
                "testing": 0.8,
                "art": 0.5,
                "prevention": 0.7,
                "pmtct": 0.6
            }
        },
        "pessimistic": {
            "multiplier": 0.8,
            "description": "20% decrease in funding",
            "sensitivity_by_category": {
                "testing": 0.8,
                "art": 0.5,
                "prevention": 0.7,
                "pmtct": 0.6
            }
        }
    },
    "transition_parameters": {
        "description": "Parameters controlling transition from historical to scenario-specific values",
        "default_transition_year": 2024,
        "transition_duration_years": 2,
        "interpolation_method": "smooth_sigmoid"
    }
}
